Intravenous sedative-hypnotic
This page covers all Intravenous sedative-hypnotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GABA-A receptor.
Targets
Marketed (6)
- total intravenous anaesthesia with Propofol. · Centre Hospitalier Universitaire Dijon · Anesthesiology
Propofol is a rapid-acting intravenous sedative-hypnotic that enhances inhibitory GABA neurotransmission in the central nervous system to produce unconsciousness and anesthesia. - Manual titration of propofol · Brugmann University Hospital · Anesthesia
Propofol is an intravenous sedative-hypnotic agent that enhances inhibitory GABAergic neurotransmission in the central nervous system to produce sedation and anesthesia. - Propofol Injection · Second Affiliated Hospital, School of Medicine, Zhejiang University · Anesthesia
Propofol is a rapid-acting intravenous sedative-hypnotic agent that enhances inhibitory GABA neurotransmission in the central nervous system. - Administering propofol · Iuliu Hatieganu University of Medicine and Pharmacy · Anesthesia
Propofol is a rapid-acting intravenous sedative-hypnotic agent that enhances inhibitory GABAergic neurotransmission in the central nervous system. - Sedation Propofol · RenJi Hospital · Anesthesia/Sedation
Propofol is a rapid-acting intravenous sedative-hypnotic that enhances inhibitory GABA neurotransmission in the central nervous system. - Propofol as induction agent · Fayoum University Hospital · Anesthesiology
Propofol is a rapid-acting intravenous sedative-hypnotic that enhances inhibitory GABA neurotransmission in the central nervous system to induce unconsciousness.
Phase 3 pipeline (1)
- ICI35,868 (Diprivan) · AstraZeneca · Anesthesia
Propofol is a rapid-acting intravenous sedative-hypnotic agent that enhances inhibitory GABAergic neurotransmission in the central nervous system.
Patent intelligence
- intravenous sedative hypnotic patent landscape — aggregated cliff calendar, attackable patents, originator estates